维普期刊资源整合服务平台（V6.5）

25篇 您的检索式：作者名="Scheinberg DA"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Elimination of human leukemia by monoclonal antibodies in an athymic nude mouse leukemia model 显示文摘	Xu Y Scheinberg DA	1995	Clin Cancer Res1995，1，10：	1
2	Anti- cyclic citrullinated peptide antibodies in advanced rheumatoid ar- thritis显示文摘	Pinheiro GC Scheinberg MA Aparecida da Silva M	2003	Ann Intern Med2003，139，3：	1
3	Radioimmunotherapy for acute leukemia显示文摘	Jurcic JG Scheinberg DA	2002	Cancer Control2002，9，2：	1
4	Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering显示文摘	Scheinberg P Price DA Ambrozak DR	2006	Exp Hematol2006，34，：	1
5	Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia显示文摘	Dumont L Scheinberg DA	1998	Clin Cancer Res1998，4，6：	1
6	Elimination of human leukemia by monoclonal antibodies in an athymic nude mouse leukemia model显示文摘	Xu Y Scheinberg DA	1995	Clin Cancer Res1995，1，10：	1
7	Immunotherapeutic approaches for hematologic malignancies显示文摘	Caligiuri MA Velardi A Scheinberg DA	2004	Hematology Am Soc Hematol Educ Program2004，，：	1
8	Immunisation with BCG and recombinant MVA85A induces long-lasting,polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations显示文摘	Beveridge NE Price DA Casazza JP Pathan AA Sander CR Asher TE Ambrozak DR Precopio ML Scheinberg P Alder NC Roederer M Koup RA Douek DC Hill AV McShane H	2007	Eur J Immunol2007，37，11：	1
9	Restricted expression of an early myeloid and monocytic cell surface anti- gen defined by monoclonal antibody M195显示文摘	Tanimoto M Scheinberg DA Cordon-Cardo C et 01	1989	Leukemia1989，3，5：	1
10	Anticyclic citrullinated peptide antibodies in advanced rheumatoid arthritis显示文摘	Pinheiro G C Scheinberg M A Aparecida da Silva M Maciel S	2003	Ann Intern Med2003，139，：	1
11	Cell surface receptor-targeted therapy of acute myeloid leukemia显示文摘	Frankel AE Sievers EL Scheinberg DA	2000	Cancer Biother Radiopharm2000，15，5：	1
12	Prognostic significance of minimal residual disease detection and PML/RARα isoform type:long-term follow-up in acute promyelocyetic leukemia显示文摘	Jurcic JG Nimer SD Scheinberg DA	2001	Blood2001，98，9：	1
13	Conscripts of the in- finite armada: systemic cancer therapy using nanomaterials 显示文摘	Scheinberg DA Villa CH Escorcia FIE	2010	Nat Rev Clin Onco12010，7，5：	1
14	A phase I trial of humanized monoclonal antibody HuM195 (anti-CD33) with low dose interleukin 2 in acute myelogenous leukemia 显示文摘	Kossman SE Scheinberg DA Jurcic JG	1999	Clin Cancer Res1999，5，10：	1
15	A phase I trial of humanized antibody HuM195(anti-CD33) with low dose interleuldn-2 in acute myelogenous leukemia显示文摘	Kossman SE Scheinberg DA Jurcic JG	1999	Clin Cancer Res1999，5，10：	1
16	Prognostic significanceof minimal residual disease detection and PML/RAR-alpha iso-form type:long-term follow-up in acute promyelocytic leukemia显示文摘	Jurcic JG Nimer SD Scheinberg DA	2001	Blood2001，98，9：	1
17	Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia显示文摘	Caron PC Dument L Scheinberg DA	1998	Clin Cancer Res1998，4，6：	1
18	Prognostic significance of minimal residual disease detection and PML/RARa isoform type :long-term follow-up in acute promyelocytie leukemia 显示文摘	Jurcic JG Nimer SD Scheinberg DA	2001	Blood2001，98，9：	1
19	Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction:Implications for graft engineering显示文摘	Scheinberg P Price DA Ambrozak DR	2006	Exp Hematol2006，34，6：	1
20	Prognostic significance of minimal residual disease detection and PML/RAR isoform type:long-term follow-up in acute promyelocytic leukemia显示文摘	Juric JG Nimer SD Scheinberg DA		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示